health catalyst - Search News

Health Catalyst Reports Fourth Quarter and Year End 2024 Results

SALT LAKE CITY, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2024.

YAHOO!Finance · 23h

Why Health Catalyst (HCAT) Shares Are Trading Lower Today

Shares of healthcare software provider Health Catalyst (NASDAQ:HCAT) fell 20.9% in the morning session after the company reported poor fourth-quarter results, with full-year revenue guidance missing expectations.

Seeking Alpha · 1d

Health Catalyst, Inc. (HCAT) Q4 2024 Earnings Call Transcript

Q4 2024 Earnings Call Transcript February 26, 2025 5:00 PM ETCompany ParticipantsJack Knight - Vice President,

SFGate · 1d

Health Catalyst: Q4 Earnings Snapshot

SOUTH JORDAN, Utah (AP) — SOUTH JORDAN, Utah (AP) — Health Catalyst Inc. (HCAT) on Wednesday reported a loss of $20.7 million in its fourth quarter. The South Jordan, Utah-based company said it had a loss of 33 cents per share. Earnings, adjusted for stock option expense and amortization costs, came to 4 cents per share.

Business Insider · 1d

Health Catalyst (HCAT) Gets a Buy from William Blair

In a report released today, Ryan Daniels from William Blair reiterated a Buy rating on Health Catalyst (HCAT – Research Report). The company’s

Hosted on MSN2h

Signature Healthcare selects Ignite ecosystem to improve analytic capabilities

The healthcare delivery system will use Ignite to achieve its goals, including the integration of clinical and claims data.

21h

Health Catalyst announces multiyear agreement with Signature Health

Health Catalyst (HCAT) announced a multi-year agreement with Signature Healthcare, an integrated healthcare delivery system serving ...

Health Catalyst (HCAT) Misses Q4 Earnings and Revenue Estimates

Health Catalyst (HCAT) delivered earnings and revenue surprises of -63.64% and 0.28%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Hosted on MSN1d

Health Catalyst’s (NASDAQ:HCAT) Q4 Earnings Results: Revenue In Line With Expectations, Growth To Accelerate Next Year

Healthcare software provider Health Catalyst (NASDAQ:HCAT) in Q4 CY2024, with sales up 6% year on year to $79.61 million. On ...

The Herald Journal23h

Signature Healthcare to Enhance Analytics by Leveraging Health Catalyst Ignite™

Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare ...

Teladoc Health: Needs A Growth Catalyst

Teladoc Health is a beaten-down stock with stagnant revenue, priced attractively relative to its sector. Read why I rate TDOC ...

Health Catalyst, Inc.: Health Catalyst Reports Fourth Quarter and Year End 2024 Results

Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results